Double Medical Technology Inc. (SHE:002901)
China
· Delayed Price · Currency is CNY 35.74
+0.48 (1.36%)
Apr 2, 2025, 2:45 PM CST
Double Medical Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Operating Revenue | 1,929 | 1,525 | 1,428 | 1,989 | 1,583 | 1,255 | Upgrade
|
| Other Revenue | 8.39 | 8.39 | 5.94 | 5.02 | 3.39 | 2.08 | Upgrade
|
| Revenue | 1,937 | 1,533 | 1,434 | 1,994 | 1,587 | 1,257 | Upgrade
|
| Revenue Growth (YoY) | 46.22% | 6.91% | -28.09% | 25.68% | 26.21% | 62.77% | Upgrade
|
| Cost of Revenue | 655.36 | 541.52 | 344.6 | 319.12 | 230.65 | 184.41 | Upgrade
|
| Gross Profit | 1,282 | 991.6 | 1,089 | 1,675 | 1,356 | 1,073 | Upgrade
|
| Selling, General & Admin | 753.06 | 690.48 | 788.18 | 746.94 | 565.3 | 455.04 | Upgrade
|
| Research & Development | 308.12 | 285.28 | 256.72 | 167.07 | 128.02 | 100.38 | Upgrade
|
| Other Operating Expenses | 45.84 | -2.51 | 15.77 | 27.52 | 21.51 | 15.31 | Upgrade
|
| Operating Expenses | 1,108 | 972.33 | 1,059 | 957.77 | 723.13 | 583.04 | Upgrade
|
| Operating Income | 173.94 | 19.27 | 30.9 | 717.45 | 633.08 | 489.87 | Upgrade
|
| Interest Expense | -8.99 | -7.16 | -3.1 | -0.55 | - | - | Upgrade
|
| Interest & Investment Income | 45.47 | 39.65 | 37.23 | 34.63 | 28.53 | 33.26 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.77 | 0.77 | 7.62 | -5.87 | -10.05 | 1.69 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.58 | -0.33 | -0.32 | -0.2 | -0.14 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | 209.61 | 52.21 | 72.33 | 745.45 | 651.42 | 524.72 | Upgrade
|
| Impairment of Goodwill | -0.86 | -0.86 | -1.37 | -0.91 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 6.53 | 5.6 | 1.77 | 1.22 | 2.52 | 0.07 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.44 | 0.3 | -1.73 | -0 | -0.12 | 0.01 | Upgrade
|
| Asset Writedown | -23.41 | -0.02 | -0.54 | -0.03 | -0.06 | -0.6 | Upgrade
|
| Legal Settlements | - | - | - | -19.1 | -2.4 | - | Upgrade
|
| Other Unusual Items | 65.68 | 42.51 | 77 | 75.88 | 58.28 | 44.78 | Upgrade
|
| Pretax Income | 257.12 | 99.74 | 147.46 | 802.51 | 709.63 | 568.98 | Upgrade
|
| Income Tax Expense | 25.1 | 13.4 | 37.89 | 111.01 | 94.88 | 90.27 | Upgrade
|
| Earnings From Continuing Operations | 232.02 | 86.34 | 109.57 | 691.5 | 614.75 | 478.71 | Upgrade
|
| Minority Interest in Earnings | -30.88 | -27.36 | -17.01 | -18.19 | -9.07 | -13.21 | Upgrade
|
| Net Income | 201.13 | 58.97 | 92.56 | 673.31 | 605.68 | 465.49 | Upgrade
|
| Net Income to Common | 201.13 | 58.97 | 92.56 | 673.31 | 605.68 | 465.49 | Upgrade
|
| Net Income Growth | - | -36.28% | -86.25% | 11.16% | 30.12% | 25.32% | Upgrade
|
| Shares Outstanding (Basic) | 421 | 421 | 421 | 401 | 401 | 401 | Upgrade
|
| Shares Outstanding (Diluted) | 421 | 421 | 421 | 403 | 401 | 401 | Upgrade
|
| Shares Change (YoY) | -0.46% | 0.13% | 4.35% | 0.52% | -0.04% | 0.47% | Upgrade
|
| EPS (Basic) | 0.48 | 0.14 | 0.22 | 1.68 | 1.51 | 1.16 | Upgrade
|
| EPS (Diluted) | 0.48 | 0.14 | 0.22 | 1.67 | 1.51 | 1.16 | Upgrade
|
| EPS Growth | - | -36.36% | -86.83% | 10.60% | 30.17% | 24.73% | Upgrade
|
| Free Cash Flow | -26.44 | -231.85 | -156.63 | 438.15 | 418.64 | 114.59 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.55 | -0.37 | 1.09 | 1.04 | 0.29 | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | - | 0.500 | 0.800 | 0.600 | Upgrade
|
| Dividend Growth | - | - | - | -37.50% | 33.33% | 20.00% | Upgrade
|
| Gross Margin | 66.16% | 64.68% | 75.97% | 84.00% | 85.47% | 85.33% | Upgrade
|
| Operating Margin | 8.98% | 1.26% | 2.15% | 35.97% | 39.90% | 38.96% | Upgrade
|
| Profit Margin | 10.38% | 3.85% | 6.45% | 33.76% | 38.17% | 37.02% | Upgrade
|
| Free Cash Flow Margin | -1.36% | -15.12% | -10.92% | 21.97% | 26.38% | 9.11% | Upgrade
|
| EBITDA | 282.18 | 118.07 | 117.12 | 782.07 | 683.41 | 529.66 | Upgrade
|
| EBITDA Margin | 14.57% | 7.70% | 8.17% | 39.22% | 43.07% | 42.13% | Upgrade
|
| D&A For EBITDA | 108.24 | 98.8 | 86.22 | 64.62 | 50.33 | 39.79 | Upgrade
|
| EBIT | 173.94 | 19.27 | 30.9 | 717.45 | 633.08 | 489.87 | Upgrade
|
| EBIT Margin | 8.98% | 1.26% | 2.15% | 35.97% | 39.90% | 38.96% | Upgrade
|
| Effective Tax Rate | 9.76% | 13.44% | 25.70% | 13.83% | 13.37% | 15.87% | Upgrade
|
| Revenue as Reported | 1,937 | 1,533 | 1,434 | 1,994 | 1,587 | 1,257 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.